- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04363125
Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus
Systematic Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Isolated hypoganglionosis is rare and constitutes 3-5% of all congenital neurological bowel diseases. Since hypoganglionosis is associated with symptoms such as chronic constipation or pseudo-obstruction, it can be confused with Hirschprung's disease and it is important to make a differential diagnosis before treatment. Our aim in this study; In addition to sharing the rarely isolated hypoganglionosis and sigmoid volvulus in a 45-year-old male patient with mental retardation, the investigators present a systematic comprehensive review of hypoganglionosis. Pubmed and Scopus databases were scanned. No restrictions were used in the written language. Only isolated cases of hypoganglionosis were added to the study. In the cases; author, year of publication, country of publication, age, gender, surgical or non-surgical treatments, treatment results, and mortalities were examined.
When sigmoid volvulus is seen in children and adolescents, congenital neurological bowel diseases should be considered in the differential diagnosis. Hirschprung's disease must be ruled out by rectal biopsy. The histopathological investigation should be carried out for the diagnosis and determination of surgical margins in isolated hypoganglionosis.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Gaziantep, Turkey
- Dr. Ersin Arslan Training and Resource Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- isolated hypoganglionosis
- our case of isolated hypoganglionosis
Exclusion Criteria:
- hypoganglionosis with Hirschsprung's disease
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: three months
|
Mortality of sigmoid volvulus due to isolated hypoganglionosis
|
three months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23042020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pathology
-
University of RochesterAmerican Orthopaedic Foot and Ankle SocietyCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Consorci Sanitari de TerrassaUnknownGynecological PathologySpain
-
University Hospital, Strasbourg, FranceUnknownRespiratory Pathology | Obstructive SyndromeFrance
-
University Hospital, MotolCompletedECMO Primary Hemostasis PathologyCzechia
-
Arthrex, Inc.RecruitingDegenerative and Traumatic Pathology of the Knee | Degenerative and Traumatic Pathology of the Shoulder and Elbow | Degenerative and Traumatic Pathology of the Foot and Ankle | Degenerative and Traumatic Pathology of the Hand and Wrist | Degenerative and Traumatic Pathology of the HipUnited States, United Kingdom, Canada, Puerto Rico, South Africa
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
Rigshospitalet, DenmarkCompleted
-
Hamamatsu Photonics K.K.Completed
Clinical Trials on Pathology result
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
Geisinger ClinicNational Human Genome Research Institute (NHGRI)Active, not recruitingLynch Syndrome | Familial Hypercholesterolemia | Hereditary Breast and Ovarian Cancer SyndromeUnited States
-
Yanqing LiUnknownEarly Detection of CancerChina
-
University of California, Los AngelesCompletedCOVID-19United States
-
Lucid Diagnostics, Inc.Medex15Recruiting
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
University of AarhusUnknown
-
Al-Azhar UniversityCompleted
-
Imperial College LondonRecruitingAnal Cancer | Human Papilloma Virus | Anal Intraepithelial Neoplasia | Genital Neoplasm | Genital CancerUnited Kingdom